📰 Mark Upsdell News
Page 3 - Mark Upsdell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Upsdell. Real-time updates on events, politics, business and more.
September 13, 2022
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated August 29, 2022, the Company and its auditors are continuing to work diligentl...
August 12, 2022
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12...
July 14, 2022
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT”), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203...
May 12, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
May 12, 2022
Rapid Dose Therapeutics Corp. ("RDT"), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, provides the following update regarding the signing
March 8, 2022
Value of needle-free vaccination, such as the QuickStrip™, will be discussedBURLINGTON, Ontario--(BUSINESS WIRE)--#100DaysMission--Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery med...
March 8, 2022
Value of needle-free vaccination, such as the QuickStrip, will be discussed Rapid Dose Therapeutics Corp. ("RDT" or the"Company") (CSE: DOSE), a Canadian biotechnology company focused on health and
December 22, 2021
Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant - read this article along with other careers information, tips and advice on BioSpace
December 15, 2021
Additions to support immediate commercialization efforts for the Company’s COVID-19 vaccine candidate
December 9, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.